Cholinesterase levels in active working, pregnant, menstruating, menopausal, or contraceptive user women

Authors

  • Jaime Carmona-Fonseca

DOI:

https://doi.org/10.18597/rcog.576

Keywords:

cholinesterase, sexual hormone status, female workers

Abstract

Objective: to measure erythrocyte (EC 3.1.1.7), plasma (EC 3.1.1.8) and whole blood cholinesterases in active working women classified according to their sexual hormone status (SHS).

Methodology: in a cholinesterase reference values study (descriptive, prospective, cross sectional) carried out among the working population of Valle de Aburrá and Oriente Cercano Antioqueño (Antioquia, Colombia), a total of 430 women give information about SHS. The enzymatic activity was measured in plasma and erythrocytes using Michel's electrometric and EQM colorimetric techniques. Plasma values were also measured by Monotest® (Boehringer Mannheim kinetics) and whole blood values were measured by Lovibond®, a colorimetric test.

Results: in 430 out of 437 women a "declared hormonal status" was known (pregnant, menstruating, other). Upon age association, a "deduced hormonal state" was established (pregnant, menstruating, non-pregnant non-menstruating, menopause). During analyses, 21 women with anemia were excluded and the included (409 women) were distributed as follows: 13 pregnant, 47 menstruating , 307-non pregnant non-menstruating, 42 menopause. Erythrocyte and whole blood cholinesterase were statistically similar among the groups, but plasma values were significantly higher in menopause subjects, followed by non pregnant-no menstruating, lower in menstruating and very low in pregnant. The most significant difference was observed between the menopausic and pregnant groups. The two other groups evidenced similar values.

Conclusion: plasma concentration of the enzyme changes with SHS whichever test is applied. The lowest values were observed in pregnant and the highest in menopause women. These two groups coincide with the highest and the lowest female hormone load, between these two groups are the users of hormone therapy replacement, ovulation inhibitors users and those under no hormone treatment.

Author Biography

Jaime Carmona-Fonseca

Médico salubrista, epidemiólogo, ARP Seguro Social, Medellín. Profesor titular, facultad de Medicina, Universidad de Antioquia.

References

Rider JA, Hodges JL Jr, Swader J, Wiggins AD. Plasma and cell cholinesterase in 800 "healthy" blood donors. J Lab Clin Med. 1957; 50: 376-383.

EQM Research Inc. (Cincinnati, Ohio, USA). Cholinesterase kit for the field determination of pesticide exposure. Instruction manual. Cincinnati (Ohio): EQM, 1994.

Carmona-Fonseca J, Henao S, Garcés R. Valores de referencia de actividad colinesterásica sanguínea en población laboral activa no expuesta a plaguicidas inhibidores de colinesterasa. Rev Fac Nal Sal Públ (Medellín) 2000; 18 (2): 55-72.

Henao S, Corey G. Plaguicidas inhibidores de las colinesterasas. Serie Vigilancia 11. Centro Panamericano de Ecología Humana y Salud, 1991, Metepec, México: ECO, OPS, OMS.

Abou-Hatab K, O'Mahony MS, Patel S, Woodhouse K. Relationship between age and plasma esterases. Age Ageing 2001; 30 (1): 41-45.

Henao S, Zapata FM, Restrepo MP, Marín LE, Ramírez H, Corrales R et al. Actividad colinesterásica en menores trabajadores. Antioquia (Colombia), 1989-1990. Medellín: Instituto de Seguros Sociales y Universidad de Antioquia, 1990.

Karlsen RL, Sterri S, Lyngaas S, Fonnum F. Reference values for erythrocite acetylcholinesterases and plasma cholinesterase activities in children, implications for organophosphate intoxication. Scand J Clin Lab Invest. 1981; 41 (3): 301-302.

García-López JA, Monteoliva M. Physiological changes in human erythrocyte cholinesterase as measured with the "pH-stat". Clin Chem. 1988; 34 (19): 2133-2135.

Chan L. Blood cholinesterase levels in the elderly and newborn. Malays J Pathol 1995 Dec;17(2):87-9.

González-Horta MC, Casillas-Ituarte N, Erives-Quezada G, Reza-López S, Sanín-Aguirre LH, Levario-Carrillo M. Actividad de la acetilcolinesterasa durante el embarazo y en el recién nacido. Ginecol Obstet Méx. 2000; 68 (6): 231-235.

Rumenjak V. Distribution of human erythrocytes cholinesterase according to age, sex and pregnancy. Acta Med Croatica 1998; 52 (3): 187-189.

Brock DJ, Barron L. Prospective prenatal screening for fetal abnormalities using a quantitative immunoassay for acetylcholinesterase. J Med Genet 1988; 25 (9): 606-608.

de Peyster A, Willis WO, Liebhaber M. Cholinesterase activity in pregnant women and newborns. J Toxicol Clin Toxicol 1994; 32 (6): 683-696.

Venkataram BV, Iyer GY, Narayanan R, Joseph T. Erythrocyte and plasma cholinesterase activity in normal pregnancy. Indian J Phisiol Pharmacol 1990; 34 (1): 26-28.

Brennand DM, Jehanli AM, Wood PJ, Smith JL. Raised levels of maternal serum secretory acetylcholinesterase may be indicative of fetal neural tube defects in early pregnancy. Acta Obst Gynecol Scand 1998; 77 (1): 8-13.

Evans RT, Wroe J M. Plasma cholinesterase changes during pregnancy. Their interpretation as a cause of suxamethonium-induced apnoea. Anaesthesia 1980; 35 (7): 651-654.

Whittaker M. Cholinesterase. New York, Karger Basel. 1986. Monographs in Human Genetics, Nº 11.

Howard JK. Plasma cholinesterase activity in early pregnancy. Arch Environ Health 1978; 33 (5): 277-279.

Robson N, Robertson I, Whittaker M. Plasma cholinesterase changes during the puerperium. Anaesthesia 1986; 41 (3): 243-249 .

Evans RT, O'Callaghan J, Norman A. A longitudinal study of cholinesterase changes in pregnancy. Clin Chem 1988; 34 (11): 2249-2252.

Whittaker M, Crawford JS, Lewis M. Some observations of levels of plasma cholinesterase activity within an obstetric population. Anaesthesia 1988; 43 (1): 42-45.

Davies JM, Carmichael D, Dymond C. Plasma cholinesterase and trophoblastic disease. Gestational trophoblastic disease and reduced activity of plasma cholinesterase. Anaesthesia 1983; 38 (11): 1071-1074.

Galbraith DA. Human erythrocyte acetylcholinesterase in relation to cell age. Biomedical J. 1981; 195: 221-228.

Kamada T, McMillan DE, Yamashita T, Otsuji S. Lowered membrane fluidity of younger erythrocytes in diabetes. Diabetes Res Clin Pract 1992; 16 (1): 1-6.

Hayes W Jr. Pesticides studies in man. Baltimore, Maryland, USA, Williams and Wilkins, 1982.

Reuter W, Geus P. Behavior of cholinesterase activity in lipid metabolism disorders. Z Gesamte Inn Med 1987 Jul 1;42(13):371. Resumen consultado el 1 noviembre 2002 en: http://www.ncbi.nlm.nih.gov PMID 3630286.

Kaloyanova F. Toxicity of selected groups of pesticides: organophosfates. In: World Health Organization, Regional Office for Europe. Toxicology of pesticides. Copenhagen, Denmark: WHO, 1982: 133-144. Health Aspects of Chemical Safety; Interim Document Nº 9.

Jain AK, Hussain S, Ahuja S. Undernutrition in children. Effect on vecuronium indiced neuromuscular blockade. Anaesth Intensive Care 1999; 27 (4): 381-384.

Camarero-González E, Muñoz V, Iglesias M, Fernández JA, Cabezas J. Desnutrición proteico-calórica: sus efectos sobre cuatro parámetros metabólicos. Nutr Hosp 1995; 10 (3): 158-160.

Garry PJ. A manual and automated procedure for measuring serum cholinesterase activity and identifying enzyme variants. Clin Chem Acta 1971; 17 (3): 192-198.

Coye MJ, Lowe JA, May KJ. Biological monitoring of agricultural workers exposed to pesticides: J Occupational Med 1986; 28 (8): 619-627 (part I); 628-638 (part II).

Kalow WGK. A method for determination of atypical forms of human serum cholinesterase: determination of dibucaine number. Canadian J Biochemical Physiology 1957; 35: 339.

Shinohara K, Tanaka KR. Hereditary deficiency of erythrocyte acetylcholinesterase. Am J Hematol 1979; 7 (4): 313-321.

Primo-Parmo SL, Chautard-Freire-Maia EA. Absense of linkage between the serum cholinesterase (CHE1) and rhesus (RH) loci. Hum Genet. 1982; 60 (3): 284-286.

Ruprecht B, Schurmann M, Ziegenhagen MW, vom Bauer E, Meir D, Schlaak M et al. Corrected normal values for serum ACE by genotyping the deletion/insertion-polymorphism of the ACE gene. Pneumologie 2001; 55 (7); 326-332. Resumen consultado el 31 octubre 2002 en http://www.ncbi.nlm.nih.gov. PMID: 11481579.

Morton F. Detection of cholinesterase inhibition. The significance of cholinesterase measurements. Ann Clin Lab Sci. 1988; 18 (5); 345-452.

Gerreiro, JF, Santos, SEB, Black, FL. Frequencies of the atypical and C5 variants of serum cholinesterase in Wayana - Apalai Indians. Rev Bras Genet. 1985; 8 (1): 123-129.

Rosalki SB. Genetic influences on diagnostic enzymes in plasma. Enzyme 1988; 39 (2): 95-109.

Ando M, Hirosaki S, Tamura K, Taya T. Multiple regression analysis of the cholinesterase activity with certain physiochemical factors. Environ Res. 1984; 33 (1): 96-105.

den Blaauwen DH, Poppe WA, Tritschler W. Cholinesterase (EC 3.1.1.8) with butyrylthiocholineiodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy. J Clin Chem Clin Biochem 1983; 21: 381-388. Resumen consultado el 1 noviembre 2002 en: http://www.ncbi.nlm.nih.gov. PMID 6886638. Citado por Boehringer Mannheim en el folleto instructivo sobre Monotest® (Boehringer Mannheim).

How to Cite

1.
Carmona-Fonseca J. Cholinesterase levels in active working, pregnant, menstruating, menopausal, or contraceptive user women. Rev. colomb. obstet. ginecol. [Internet]. 2003 Jun. 30 [cited 2024 May 17];54(3):146-5. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/576

Downloads

Download data is not yet available.

Published

2003-06-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views